Construction of a Risk Prediction Model of Extended Release Oxycodone Tablet-Induced Nausea and Clarification of Predictive Factors-Reference-Cited by-同舟云学术

Construction of a Risk Prediction Model of Extended Release Oxycodone Tablet-Induced Nausea and Clarification of Predictive Factors

Published:2021-04-01 Issue:4 Volume:44 Page:593-598
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Kumai Masayoshi¹²,Imai Shungo³,Kato Shintaro¹²,Koyanagi Ryo¹²,Tsuruga Kenkichi²,Yamada Takehiro⁴,Takekuma Yoh¹,Sugawara Mitsuru¹³

Affiliation:

1. Department of Pharmacy, Hokkaido University Hospital

2. Cancer Center Palliative Care Team, Hokkaido University Hospital

3. Laboratory of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hokkaido University

4. Department of Pharmacotherapy, Faculty of Pharmaceutical Sciences, Hokkaido University of Science

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/44/4/44_b20-01028/_pdf

Reference21 articles.

1. 1) Laugsand EA, Kaasa S, Klepstad P. Management of opioid-induced nausea and vomiting in cancer patients: systematic review and evidence-based recommendations. Palliat. Med., 25, 442–453 (2011).

2. 2) Clinical Guidelines for Cancer Pain Management, Third Edition. KANEHARA & Co., Ltd., Tokyo, Japan (2020).

3. 3) Ishihara M, Ikesue H, Matsunaga H, Suemaru K, Kitaichi K, Suetsugu K, Oishi R, Sendo T, Araki H, Itoh Y. A multi-institutional study analyzing effect of prophylactic medication for prevention of opioid-induced gastrointestinal dysfunction. Clin. J. Pain, 28, 373–381 (2012).

4. 4) Ariyoshi K, Kitahara T, Ryu E, Takada M, Munakata C, Nose S. Clinical risk factors associated with nausea and vomiting in patients receiving extended-release oxycodone. Japanese J. Pharm. Heal. Care Sci., 39, 280–288 (2013).

5. 5) Kanbayashi Y, Hosokawa T. Predictive factors for nausea or vomiting in patients with cancer who receive oral oxycodone for the first time: is prophylactic medication for prevention of opioid-induced nausea or vomiting necessary? J. Palliat. Med., 17, 683–687 (2014).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Nausea and Vomiting Frequency Following Opioid Dose Escalation and Its Risk Factors: A Single-Center Retrospective Observational Study;Journal of Palliative Medicine;2023-09-21

2. Machine-learning-based adverse drug event prediction from observational health data: A review;Drug Discovery Today;2023-09

3. Risk evaluation of carbapenem-induced liver injury based on machine learning analysis;Journal of Infection and Chemotherapy;2023-07

4. Machine Learning-Based Prediction of Digoxin Toxicity in Heart Failure: A Multicenter Retrospective Study;Biological and Pharmaceutical Bulletin;2023-04-01